ScreenerHero

NICA Nanologica AB (publ)

STO · SE · Healthcare · Biotechnology · nanologica.com
0.2990SEK+1.36%Mkt Cap: 9.40M $P/E: 0.85

Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-ba…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap9.40M USD
Enterprise Value12.58M USD
Revenue (TTM)12.38M USD
Gross Profit410.92K USD
Net Income (TTM)-4.91M USD
Revenue/Share0.66 SEK
Last Price0.2990 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees72
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0005454873
Valuation
P/E (Trailing)0.85
P/E (Forward)1.02
PEG—
EV/EBITDA5.95
EV/Revenue1.02
P/S0.75
P/B0.62
EPS (TTM)0.35
EPS (Forward)0.29
52W Range
0.28601% of range2.250
52W High2.250 SEK
52W Low0.2860 SEK
Profitability
Gross Margin20.33%
Oper. Margin-79.84%
EBITDA Margin17.09%
Profit Margin-242.77%
ROE-226.49%
ROA-58.21%
Growth
Revenue Growth931.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.81M USD
CapEx (TTM)103.50K USD
FCF Margin2.43%
FCF Yield3.20%
Net Debt3.31M USD
Net Debt/EBITDA1.56
Balance Sheet
Debt/Equity0.95
Current Ratio2.85
Quick Ratio0.97
Book Value/Sh0.48 SEK
Cash/Share0.06 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.100 SEK
Upside (mean)+267.9%
Target Range1.100 SEK – 1.100 SEK
# Analysts1
Ownership
Shares Out.328.77M
Float251.84M
Insiders17.70%
Institutions53.84%
Technical
SMA 500.3894 (-23.2%)
SMA 2000.4861 (-38.5%)
Beta-0.04
S&P 52W Chg16.45%
Avg Vol (30d)727.36K
Avg Vol (10d)411.13K
Technical Indicators
RSI (14)35.0
MACD-0.0227
MACD Signal-0.0259
MACD Hist.+0.0032
BB Upper0.3388 SEK
BB Middle0.3140 SEK
BB Lower0.2891 SEK
BB Width15.82%
ATR (14)0.0216 SEK
Vol Ratio (20d)0.29x